Specs is actively involved in the drug discovery process with several screening collaborations.
In order to validate the quality of our products and in-house computational chemistry, Specs takes part in several screening collaborations. These collaborations are carried out in small drug discovery companies combing the strength and expertise of small biotech and pharmaceutical companies and the academic world. The results obtained in these collaborations lead to a better service and support to our customers.
Some of our current collaborations are:
- PRO-NET / Oncodrome (prostate cancer)
- Targeting the Jak2 (growth hormone metabolism)
For further information, please contact our Lead Development department. ¤